Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership17,315 shares
Latest Disclosed Value $ 13,378,255
Private Advisor Group, LLC ownership in REGN / Regeneron Pharmaceuticals, Inc.

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 17,315 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $13,378,255 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 17,768 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -2.55% during the quarter.

Private Advisor Group, LLC has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 600 of underlying shares valued at $154,410 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,315 -453 -2.55 13,378 -2.45 0.0594
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,768 -4,054 -18.58 13,715 11.78 0.0618
2025-11-13 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 21,822 2,631 13.71 12,270 21.78 0.0604
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 19,191 4,915 34.43 10,075 11.28 0.0543
2025-05-05 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 14,276 1,957 15.89 9,054 3.19 0.0548
2025-02-03 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 12,319 6,958 129.79 8,774 55.71 0.0494
2024-10-22 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,361 303 5.99 5,635 6.00 0.0350
2024-08-05 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,058 354 7.53 5,317 17.45 0.0357
2024-04-30 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,704 -180 -3.69 4,527 5.43 0.0325
2024-02-06 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,884 -58 -1.17 4,294 5.69 0.0334
2023-11-03 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,942 714 16.89 4,062 33.01 0.0363
2023-08-10 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,228 399 10.42 3,054 -2.92 0.0266
2023-05-10 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,829 212 5.86 3,146 776.32 0.0300
2023-01-18 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,617 -93 -2.51 359 -85.95 0.0181
2022-10-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,710 -3,145 -45.88 2,556 -36.94 0.0294
2022-07-13 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,855 -1,573 -18.66 4,053 -31.15 0.0361
2022-05-12 2022-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 8,428 -3,447 -29.03 5,887 -21.50 0.0451
2022-05-10 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 11,875 0 7,499 0.0564
2022-02-10 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 11,875 -8,471 -41.63 7,499 -39.10 0.0563
2021-10-14 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 20,346 2,948 16.94 12,314 26.73 0.0783
2021-08-12 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,398 1,695 10.79 9,717 30.78 0.0849
2021-04-22 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 15,703 5,246 50.17 7,430 47.07 0.0709
2021-04-01 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10,457 1,239 13.44 5,052 -5.36 0.0526
2020-11-02 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 9,218 2,167 30.73 5,338 21.40 0.0694
2020-08-17 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,051 1,260 21.76 4,397 55.48 0.0610
2020-05-12 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,791 158 2.80 2,828 33.71 0.0519
2020-02-10 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,633 220 4.06 2,115 40.81 0.0329
2019-11-13 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,413 2,276 72.55 1,502 52.95 0.0234
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,137 -204 -6.11 982 -28.43 0.0178
2019-05-13 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,341 -359 -9.70 1,372 -0.80 0.0271
2019-02-08 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,700 17 0.46 1,383 -7.06 0.0333
2018-11-01 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,683 -84 -2.23 1,488 12.64 0.0305
2018-08-09 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,767 786 26.37 1,321 28.63 0.0217
2018-05-09 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,981 -496 -14.27 1,027 -20.76 0.0402
2018-02-07 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,477 -916 -20.85 1,296 -37.06 0.0547
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,393 159 3.76 2,059 -2.69 0.0509
2017-08-10 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,234 124 3.02 2,116 36.34 0.0573
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,110 -86 -2.05 1,552 1.44 0.0434
2017-02-09 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,196 490 13.22 1,530 3.94 0.0502
2016-11-10 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,706 -87 -2.29 1,472 4.47 0.0600
2016-08-09 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,793 -193 -4.84 1,409 19.51 0.0569
2016-05-13 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,986 1,480 59.06 1,179 -13.31 0.0570
2016-02-09 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,506 371 17.38 1,360 36.96 0.0652
2015-11-13 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,135 -1,769 -45.31 993 -50.15 0.0546
2015-08-13 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,904 3,904 1,992 0.0945
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-04-24 2026-03-31 13F REGENERON PHARMACEUTICALS COM Call 600 -25.00 154 -25.96 n/a n/a n/a
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM Call 800 -52.94 208 27.61 n/a n/a n/a
2025-11-13 2025-09-30 13F REGENERON PHARMACEUTICALS COM Call 1,700 70.00 164 59.80 n/a n/a n/a
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,000 102 n/a n/a n/a
2021-04-21 2021-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-04-01 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 200 23 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.